Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?

2018 ◽  
Vol 48 (5) ◽  
pp. 638-647 ◽  
Author(s):  
Rodrigo Regacini ◽  
Andrea Puchnick ◽  
Flavio Augusto Vercillo Luisi ◽  
Henrique Manoel Lederman
Keyword(s):  
Children And Adolescents ◽  
Hodgkin Lymphoma ◽  
Whole Body ◽  
Whole Body Mri ◽  
Diffusion Weighted ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Initial Staging

Detection of distant metastases in rectal cancer: contrast-enhanced CT vs whole body MRI

2020 ◽  
Vol 31 (1) ◽  
pp. 104-111
Author(s):  
Jeong Hee Yoon ◽  
Mi Hye Yu ◽  
Bo Yun Hur ◽  
Chang Min Park ◽  
Jeong Min Lee
Keyword(s):  
Rectal Cancer ◽  
Distant Metastases ◽  
Whole Body ◽  
Whole Body Mri ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct

scholarly journals Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma

Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1007
Author(s):  
Domenico Albano ◽  
Giuseppe Micci ◽  
Caterina Patti ◽  
Federico Midiri ◽  
Silvia Albano ◽  
...  
Keyword(s):  
Whole Body ◽  
Resonance Imaging ◽  
Whole Body Mri ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Body Magnetic Resonance Imaging ◽  
18F Fdg ◽  
Fdg Pet Ct

Imaging of lymphoma is based on the use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) and/or contrast-enhanced CT, but concerns have been raised regarding radiation exposure related to imaging scans in patients with cancer, and its association with increased risk of secondary tumors in patients with lymphoma has been established. To date, lymphoproliferative disorders are among the most common indications to perform whole-body magnetic resonance imaging (MRI). Whole-body MRI is superior to contrast-enhanced CT for staging the disease, also being less dependent on histology if compared to 18F-FDG-PET/CT. As well, it does not require exposure to ionizing radiation and could be used for the surveillance of lymphoma. The current role of whole-body MRI in the diagnostic workup in lymphoma is examined in the present review along with the diagnostic performance in staging, response assessment and surveillance of different lymphoma subtypes.

scholarly journals Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas

2016 ◽  
Vol 9 ◽  
pp. CMBD.S38468 ◽  
Author(s):  
Aida Sabaté-Llobera ◽  
Montserrat Cortés-Romera ◽  
Santiago Mercadal ◽  
Javier Hernández-Gañán ◽  
Helena Pomares ◽  
...  
Keyword(s):  
B Cell ◽  
Low Dose ◽  
B Cell Lymphomas ◽  
Full Dose ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Initial Staging ◽  
Large B Cell

Pediatric Nonlymphoblastic Non-Hodgkin Lymphoma: Baseline, Interim, and Posttreatment PET/CT versus Contrast-enhanced CT for Evaluation—A Prospective Study

Radiology ◽  
2012 ◽  
Vol 262 (3) ◽  
pp. 956-968 ◽  
Author(s):  
Sameer Bakhshi ◽  
Venkatraman Radhakrishnan ◽  
Punit Sharma ◽  
Rakesh Kumar ◽  
Sanjay Thulkar ◽  
...  
Keyword(s):  
Prospective Study ◽  
Hodgkin Lymphoma ◽  
Non Hodgkin Lymphoma ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
A Prospective Study

scholarly journals PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

Blood ◽  
2016 ◽  
Vol 127 (12) ◽  
pp. 1531-1538 ◽  
Author(s):  
Sally F. Barrington ◽  
Amy A. Kirkwood ◽  
Antonella Franceschetto ◽  
Michael J. Fulham ◽  
Thomas H. Roberts ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Hodgkin Lymphoma ◽  
Early Response ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Key Points ◽  
Deauville Criteria ◽  
Modern Standard

Key Points PET-CT is the modern standard for staging Hodgkin lymphoma and can replace contrast enhanced CT in the vast majority of cases. Agreement between expert and local readers is sufficient for the Deauville criteria to assess response in clinical trials and the community.

Sign in / Sign up

Export Citation Format

Share Document